Skip to main content

Sermorelin vs Hexarelin

Both Sermorelin and Hexarelin are used for growth-hormone. Here's how their evidence, dosing, and regulatory status actually compare.

Sermorelin

Evidence B+

Sermorelin Acetate (GHRH 1-29)

The original synthetic GHRH(1–29) and the most accessible GH-stimulating peptide for age-related hormone decline. Stimulates the body's own pulsatile GH release rather than replacing it.

View full Sermorelin profile →

Hexarelin

Evidence B

Hexarelin (HEX)

The strongest GH-releasing hexapeptide and one of the few peptides with documented direct cardiac benefits in animal models. Tachyphylaxis (diminished response over time) limits long-term use.

View full Hexarelin profile →

Side-by-Side

AttributeSermorelinHexarelin
Evidence GradeB+B
FDA StatusFDA-approved (1990) for pediatric growth hormone deficiency; off-label adult use via compounding pharmaciesNot FDA-approved — research compound (cardioprotective signals investigated)
Typical Dose200–500 mcg before bed (subcutaneous)100 mcg, 1–2 times daily (subcutaneous)
Clinics Indexed22041
Categoriesgrowth-hormone, anti-aginggrowth-hormone, recovery

Key reported benefits — Sermorelin

  • Natural GH release
  • Improved sleep
  • Lean body mass
  • Recovery

Key reported benefits — Hexarelin

  • Strongest GH spike of GHRPs
  • Cardioprotective signals
  • Recovery

Educational use only

This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.

← Back to all comparisons